• Activity INFORMATION

  Overview

  Tianeptine, phenibut, and kratom are three substances abused and misused in the United States. Federally, they are not controlled, but due to the recognized abuse potential, they have varying legal status in different states. Their pharmacologic mechanisms overlap with approved medications and may cause central nervous system depression in overdose or withdrawal with abrupt cessation. This course will provide an overview of the mechanisms, clinical courses, and treatments for kratom, phenibute, and tianeptine poisoning.
  

  Handouts

  • Slide Document :   24114H05_2pp.pdf Download

  • Slide Document :   24114H05_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify treatments for overdose and withdrawal of tianeptine, phenibut, and kratom

  Define symptoms associated with use and withdrawal of tianeptine, phenibut, and kratom

  Describe the epidemiology of tianeptine, phenibut, and kratom use in the United States

  Pharmacy Technician

  Describe the epidemiology of tianeptine, phenibut, and kratom use in the United States

  Identify treatments for overdose and withdrawal of tianeptine, phenibut, and kratom

  Define symptoms associated with use and withdrawal of tianeptine, phenibut, and kratom

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1270367

  Universal Activity Number

  Pharmacist 0798-0000-24-114-H05-P
  Pharmacy Technician 0798-0000-24-114-H05-T
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  James  Leonard, PharmD, DABAT Managing Director, Washington Poison Center

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).